¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"High Risk Percutaneous Transluminal Angioplasty"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® percutaneous transluminal coronary angioplasty ÇÑ±Û °æÇǰæÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼ú=PTCA
¼³¸í   
  ¼ö¼úÀ» ÇÏÁö ¾Ê°í ÀûÀº ÇÕº´ÁõÀ¸·Î ½ÉÀ嵿¸ÆÀÇ ¹Ý°æÀ» ´ÃÀÏ ¼ö Àִ ¹æ¹ý. ½ÉÀ嵿¸Æ(Coronary artery)À̶õ, ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇϴ ½ÉÀå¿¡ Á¸ÀçÇϴ µ¿¸ÆÀ» ¸»ÇÑ´Ù. ÀÌ·± ½ÉÀ嵿¸ÆÀÌ º´ÀûÀΠ»óÅ·Π±× ³»°­ÀÌ Á¼¾ÆÁö°Ô µÇ¸é, ½ÉÀåÀÇ ÇãÇ÷ÀÌ ¹ß»ýÇÏ¿© À̸¥¹Ù Çù½ÉÁõÀ» À¯¹ßÇϰԠµÇ°í, ½ÉÇϸ頽ÉÀåÀÇ °æ»öÁõÀÌ ¹ß»ýÇϸ砰ᱹÀº È¯ÀÚÀÇ »ý¸íÀ» ¾Ñ¾Æ°£´Ù. µû¶ó¼­ ÀÌ·± Á¼¾ÆÁø ½ÉÀ嵿¸ÆÀÌ ÀÖÀ¸¸é ³ÐÇôÁÖ¾î¾ß ÇÑ´Ù.
  
  ½ÉÀ嵿¸ÆÀ» ³ÐÇôÁִ ¹æ¹ýÀ¸·Î, Ç÷Àü¿¡ ÀÇÇÑ °æ¿ì ¾à¹°À» ÀÌ¿ëÇÏ¿© ¿ëÇØ½Ãų ¼öµµ ÀÖÀ¸³ª, À̹̠¿À·¡µÈ °æ¿ì´Â ¾à¹°·Î½á Ä¡·á´Â ºÒ°¡´ÉÇÏ´Ù. À̶§ ¼ö¼úÀû ¹æ¹ý°ú ÀÌ °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼úÀû ¹æ¹ýÀº Á÷Á¢ °¡½¿À» ¿­°í ½ÉÀåÀÇ Á¼¾ÆÁø Ç÷°üÀ» Á¦°ÅÇÏ°í ´Ù¸¥ Ç÷°üÀ¸·Î ´ëÄ¡Çϴ µ¿¸ÆÀ̽ļúÀ̸ç, °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀº ÇǺθ¦ ÅëÇÏ¿© (°æÇÇÀû)ÇǺιØÀÇ µ¿¸ÆÀ» Ã£¾Æ, µ¿¸Æ¼ÓÀ» Áö³ª¼­ (°æÇ÷°ü)½ÉÀ嵿¸Æ¿¡ À̸£·¯, µ¿¸ÆÀ» È®ÀåÇϴ ¹æ¹ýÀ» ¸»ÇÑ´Ù.
¿µ¹® risk factor ÇÑ±Û À§ÇèÀÎÀÚ
¼³¸í   
  ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)°¡ 1977³â ±Ç°í¿¡¼­ ¹æ»ç¼±¹æÈ£ÀÇ ¸ñÀûÀ¸·Î Ã¤ÅÃÇÑ Áö¼ö·Î, ´ÜÀ§¼±·®(1 Sv)´ç È®·üÀû ¿µÇâÀÇ ¹ß»ýÈ®·üÀ» ÃßÁ¤ÇÏ¿© ³ªÅ¸³½ °ÍÀÌ´Ù. »ý½Ä¼± ¼±·®¿¡ ´ëÇÑ À¯ÀüÀû¿µÇâÀÇ ¹ß»ý·ü(4¡¿10£­3/Sv)À̳ª Àû»ö°ñ¼ö¼±·®¿¡ ´ëÇÑ ¹éÇ÷º´ ¹ß»ý·ü(2¡¿10£­3/Sv)µî ¿Ü¿¡ »À, ÇãÆÄ, °©»ó»ù, Á¥»ù, ±âŸ Á¶Á÷ÀÇ À§ÇèÁö¼ö¸¦ ÃøÁ¤ÇÏ¿©, È®·üÀû ¿µÇâÀÇ Àü½Å¿¡ À־ Ä¡»çÀ§ÇèÁö¼öÀÇ Çհ踦 16.5¡¿10£­3/Sv·Î ÇÏ¿´´Ù. ±×ÈÄ ICRP´Â 1990³â ±Ç°í¿¡¼­ ´ë»óÀÌ µÇ´Â Á¶Á÷°ú Àå±â¸¦ Ãß°¡Çϰí, ¼öÄ¡ °³Á¤À» Çϸ鼭 ¸íεµ °¢¸ñÀûÈ®·üÁö¼ö¶ó°íÇÏ¿´´Ù. ÀÌ ±Ç°í¿¡ ÀÇÇϸé, Ä¡»çÀû È®·üÀû ¿µÇâÀÇ È®·üÁö¼öÀÇ ÇÕ°è´Â, ÀϹÝÀο¡ ÀÖ¾î 60.0¡¿10£­3/SvÀÌ´Ù.
¿µ¹® coronary angioplasty ÇÑ±Û ½ÉÀ嵿¸Æ¼ºÇü¼ú
¼³¸í   
  Á¼¾ÆÁø ½ÉÀ嵿¸ÆÀ» È®Àå½Ã۴ ÇàÀ§¸¦ ¸»ÇÑ´Ù. ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇϴ µ¿¸ÆÀ» À̸£´Â ¸»·Î ½ÉÀå ¿ª½Ã ±ÙÀ°À̾ Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ ÀÖ´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀå¿¡ Ç÷¾×ÀÇ °ø±ÞÀÌ ¾ø¾îÁ®¼­ ½ÉÀ嵿¸Æº´À̶ó´Â º´À» ÀÏÀ¸Å²´Ù. ±×·¡¼­ ÀÌ ½ÉÀ嵿¸ÆÈ®Àå¼úÀº °ü»óµ¿¸ÆÁúȯÀÇ Ä¡·á¿¡ ÀÌ¿ëÀÌ µÈ´Ù. ´ë°³ ½ÉÀ嵿¸ÆÈ®Àå¼úÀº Å« µ¿¸Æ¿¡ ±ä °ü(Ä«Å×ÅͶó°í ÇÑ´Ù)À» ²Å¾Æ¼­ µ¿¸ÆÀ» µû¶ó °Å²Ù·Î ´ëµ¿¸Æ±îÁö À̸£°Ô ÇÏ°í ´ëµ¿¸Æ¿¡¼­ ½ÉÀ嵿¸ÆÀ» Ã£¾Æ¼­ ½ÉÀ嵿¸ÆÀ¸·Î ±ä°üÀ» ³Ö´Â´Ù. ±×¸®°í´Â Á¼¾ÆÁø ºÎÀ§¿¡ ±× °üÀÇ ³¡À» À§Ä¡½ÃŰ°í ¿©·¯ °¡Áö ±â±¸(ÁַΠdz¼±À» ÀÌ¿ëÇÑ´Ù)¸¦ ÀÌ¿ëÇØ¼­ ½ÉÀ嵿¸ÆÀ» ³ÐÈù´Ù. ÀÌ ¹æ¹ýÀ» percutaneous transluminal coronary angioplasty(ÇǺΰæÀ¯ Ç÷°ü°æÀ¯ ½ÉÀ嵿¸ÆÈ®Àå¼ú)¶ó ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous transluminal angioplasty
    ÇǺΰæÀ¯Ç÷°ü°æÀ¯Ç÷°ü¼ºÇü(¼ú)
  • percutaneous transluminal coronary angioplasty
    ÇǺΰæÀ¯Ç÷°ü°æÀ¯°ü»óµ¿¸Æ¼ºÇü(¼ú), °æÇǰæ°ü°ü»óµ¿¸Æ¼ºÇü(¼ú)
  • high risk group
    °íÀ§Ç豺
  • high risk patient
    °íÀ§ÇèȯÀÚ
  • angioplasty
    Ç÷°ü¼ºÇü(¼ú)
  • balloon angioplasty
    dz¼±Ç÷°ü¼ºÇü(¼ú)
  • percutaneous
    ÇǺΰæÀ¯-, °æÇÇ-
  • percutaneous absorption
    ÇǺΰæÀ¯Èí¼ö, °æÇÇÈí¼ö
  • percutaneous angiography
    ÇǺΰæÀ¯Ç÷°üÁ¶¿µ(¼ú), °æÇÇÇ÷°üÁ¶¿µ(¼ú)
  • percutaneous balloon dilatation
    ÇǺΰæÀ¯Ç³¼±È®Àå(¼ú), °æÇÇdz¼±È®Àå(¼ú)
  • percutaneous drainage
    ÇǺΰæÀ¯¹è¾×(¼ú), °æÇǹè¾×(¼ú)
  • percutaneous endoscopic gastrostomy
    ÇǺΰæÀ¯³»½Ã°æÀ§Ã¢³¿(¼ú), °æÇÇÀû³»½Ã°æÀ§Á¶·ç(¼ú)
  • percutaneous ethanol injection
    ÇǺΰæÀ¯¿¡Åº¿ÃÁÖ»ç, °æÇÇ¿¡Åº¿ÃÁÖ»ç
  • percutaneous gastrostomy
    ÇǺΰæÀ¯À§Ã¢³¿(¼ú), °æÇÇÀûÀ§Á¶·ç(¼ú)
  • percutaneous infection
    ÇǺΰæÀ¯°¨¿°, °æÇǰ¨¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high risk group
    °íÀ§Ç豺
  • angioplasty
    Ç÷°ü¼ºÇü¼ú
  • percutaneous transhepatic cholangiography
    ÇǺΰ£°æÀ¯¾µ°³°üÁ¶¿µ¼ú
  • percutaneous transhepatic drainage
    ÇǺΰ£°æÀ¯¹è¾×¼ú
  • percutaneous transhepatic bile drainage
    ÇǺΰ£°æÀ¯¾µ°³°ü¹è¾×(¼ú)
  • percutaneous ehtanol injection
    °æÇÇ¿¡Åº¿ÃÁÖ»ç, ÇǺΰæÀ¯¿¡Åº¿ÃÁÖ»ç
  • percutaneous
    °æÇÇ-, ÇǺΰæÀ¯-
  • high altitude
    °íÁö-, °í¼Ò-
  • risk factor
    À§ÇèÀÎÀÚ
  • low risk group
    ÀúÀ§Ç豺
  • high-dose
    °í¿ë·®
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • high grade squamous intraepithelial lesion
    °íµî±ÞÆíÆò»óÇdz»º´ÅÍ
  • high potency
    °íÈ¿´É, °í¿ª°¡, °íÀáÀç·Â
  • risk
    À§Çè, À§Çèµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous transluminal angioplasty
    °æÇǰæ°üÇ÷°ü¼ºÇü¼ú, °æÇǰæÇ÷°üÈ®Àå¼ú
  • high risk group
    °íÀ§Çèµµ±º
  • angioplasty
    Ç÷°ü¼ºÇü¼ú
  • balloon angioplasty
    dz¼±Ç÷°ü¼ºÇü¼ú
  • percutaneous absorption
    ÇǺΰæÀ¯Èí¼ö, °æÇÇÈí¼ö
  • percutaneous angiography
    °æÇÇÇ÷°üÁ¶¿µ¼ú
  • percutaneous transcatheter biliary biopsy
    °æÇǰæ°ü´ãµµ»ý°Ë¼ú, ÇǺΰæÀ¯Ä«Å×Å;µ°³±æ»ý°Ë
  • percutaneous transhepatic cholangiography
    ÇǺΰ£°æÀ¯¾µ°³°üÁ¶¿µ¼ú
  • percutaneous drainage
    ÇǺΰæÀ¯¹èÃâ
  • percutaneous balloon dilatation
    °æÇÇdz¼±È®Àå¼ú
  • percutaneous gastrostomy
    ÇǺΰæÀ¯À§Ã¢³¿¼ú, °æÇÇÀûÀ§Á¶·ç¼ú
  • percutaneous endoscopic gastrostomy
    ÇǺΰæÀ¯³»½Ã°æÀ§Ã¢³¿¼ú, °æÇÇÀû³»½Ã°æÀ§Á¶·ç¼ú
  • percutaneous infection
    °æÇǰ¨¿°, ÇǺΰæÀ¯°¨¿°
  • percutaneous irradiation
    °æÇÇÁ¶»ç
  • percutaneous ureteral stent insertion
    °æÇÇ´¢°ü½ºÅÙÆ®»ðÀÔ¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high risk group
    °íÀ§Çèµµ±º(Ë­Ëô̴̬˴).
  • high risk infant
    °íÀ§Ç輺 ¿µ¾Æ.
  • angioplasty
    Ç÷°ü¼ºÇü¼ú
  • angioplasty, balloon
    Ç÷°üÈ®Àå¼ú(úìηüªíåâú), dz¼±
  • absolute risk
    Àý´ëÀ§Çè
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • acceptable risk
    ¿ëÀÎÀ§Çèµµ, ¼ö¿ëÀ§Çèµµ
  • anesthetic risk
    ¸¶ÃëÀ§Çèµµ.
  • physical hazard =p. risk
    ½ÅüÀû À§Çè (ÊÙËøËôÌ´).
  • physical risk =physical hazard
    ½ÅüÀû À§Çè(µµ)(ËàÌ§ËøËô̴̬)
  • radiation risk
    ¹æ»ç¼±À§ÇØ, ¹æ»ç¼± À§Çè
  • radiation risk coeffecient
    ¹æ»ç¼±À§ÇèÁö¼ö
  • recurrence risk
    Àç¹ßÀ§Çè
  • relative risk
    ºñ±³À§Çèµµ(ËÓË´Ëô̴̬).
  • relative risk
    ºñ±³À§Çèµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous transluminal angioplasty
    °æÇÇ °æ°ü Ç÷°ü¼ºÇü¼ú
  • percutaneous transluminal angioplasty
    °æÇÇÀû °æÇ÷°ü Ç÷°üÈ®Àå¼ú
  • percutaneous transluminal coronary angioplasty
    °áÇÇ °æ°ü °ü»óµ¿¸Æ¼ºÇü¼ú
  • percutaneous transluminal valvuloplasty
    °æÇÇÀû °æÇ÷°üÆÇ¸·¼ºÇü(¼ú).
  • high risk group
    °íÀ§Çèµµ±º(Ë­Ëô̴̬˴).
  • high risk infant
    °íÀ§Ç輺 ¿µ¾Æ.
  • angioplasty
    Ç÷°ü¼ºÇü¼ú(úìηà÷û¡âú)
  • angioplasty
    Ç÷°ü¼ºÇü¼ú
  • angioplasty
    Ç÷°üÇü¼º¼ú, Ç÷°üÈ®Àå(¼ú).
  • angioplasty, balloon
    Ç÷°üÈ®Àå¼ú(úìηüªíåâú), dz¼±
  • balloon angioplasty
    dz¼± Ç÷°ü¼ºÇü¼ú
  • absolute risk
    Àý´ëÀ§Çè
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • acceptable risk
    ¿ëÀÎÀ§Çèµµ, ¼ö¿ëÀ§Çèµµ
  • alcohol, cancer risk
    ¾ËÄÚ¿Ã, ¾Ï À§ÇèÀÎÀÚ(äßêËúÏì×í­), ¾Ï À§Çèµµ(äßêËúÏÓø)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous infection
    °æÇǰ¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • high-energy ion scattering
    °í(ÍÔ)¿¡³ÊÁö À̿»ê¶õ(ߤկ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
  • high-level promoter
    °íÀ§(ÍÔêÈ)ÇÁ·Î¸ðÅÍ
  • high-lipid lipoprotein
    °íÁöÁú ÁöÁú´Ü¹éÁú(ÍÔò·òõò¢òõÓ±ÛÜòõ)
  • high-mannose glycoproteins
    ´Ù(Òý)¸¸³ë½º ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • high-mannose oligosaccharides
    ´Ù(Òý)¸¸³ë½º °ú´çÁú(ÍûÓØòõ)
  • high-mobility group
    °íÀ̵¿µµ ±º(ÍÔì¹ÔÑÓøÏØ)
  • high-performance liquid chromatography
    °í¼º´É(ÍÔàõÒö) ¾×ü(äûô÷) Å©·Î¸¶Åä±×·¡ÇÇ
  • high-potential iron protein
    °íÀüÀ§(ÍÔï³êÈ) ö´Ü¹éÁú(ôÑÓ±ÛÜòõ)
  • high-pressure liquid chromatography
    °í¾Ð(ÍÔäâ) ¾×ü(äûô÷)Å©·Î¸¶Åä±×·¡ÇÇ
  • high-quality proteins
    °í±Þ ´Ü¹éÁú(ÍÔÐäÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous transluminal angioplasty
    °æÇÇÀû°æÇ÷°üÇ÷°üÈ®Àå(¼ú)
  • percutaneous transluminal coronary angioplasty
    °áÇǰæ°ü°ü»óµ¿¸Æ¼ºÇü¼ú
  • percutaneous transluminal valvuloplasty
    °æÇÇÀû°æÇ÷°üÆÇ¸·¼ºÇü(¼ú)
  • high risk group
    °íÀ§Çèµµ±º
  • angioplasty
    Ç÷°üÇü¼º¼ú, Ç÷°üÈ®Àå¼ú
  • balloon angioplasty
    dz¼±Ç÷°ü¼ºÇü¼ú
  • radiation risk
    ¹æ»ç¼±À§ÇØ, ¹æ»ç¼±À§Çè
  • risk
    À§Çè(µµ), À§Ç輺
  • risk factor
    À§Çè¿äÀÎ
  • angiography, percutaneous
    °æÇÇÇ÷°üÁ¶¿µ¼ú
  • percutaneous
    °æÇÇÀÇ
  • percutaneous alcohol sclerotherapy
    °æÇÇ(Àû)¾ËÄݰæÈ­¿ä¹ý
  • percutaneous angiography
    °æÇÇÀûÇ÷°üÁ¶¿µ¼ú
  • percutaneous balloon dilatation
    °æÇÇÀûdz¼±È®Àå¼ú
  • percutaneous catheter drainage
    °æÇÇÀûµµ°ü¹è¾×¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PTCA   1) Percutaneous Transluminal Coronary Angioplasty
    ; °æÇÇÀû °æÇ÷°ü °ü...
RPTA Renal Percutaneous Transluminal Angioplasty
PICA percutaneous transluminal coronary angioplasty; Porch Index of Communicative Abilities; posterior in...
PTA parallel tubular arrays; parathyroid adenoma; percutaneous transluminal angioplasty; peroxidase-labe...
PTBA percutaneous transluminal balloon angioplasty
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PTCA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
PTA Percutaneous Transluminal Angioplasty
PTRA Percutaneous Transluminal Renal Angioplasty
PTCA Percutaneous transluminal angioplasty
PTA Percutaneous transluminal balloon angioplasty
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • percutaneous transluminal angioplasty
    °æÇÇÀû °æÇ÷°ü Ç÷°ü È®Àå, °æÇÇÀû °æÇ÷°ü Ç÷°ü È®Àå¼ú
  • percutaneous transluminal coronary angioplasty
    °áÇÇ °æ°ü °ü»ó µ¿¸Æ ¼ºÇü¼ú
  • high risk group
    °íÀ§Çèµµ±º
  • balloon angioplasty
    dz¼±À» ÀÌ¿ëÇÑ ¼ö¼ú
  • absolute risk
    Àý´ë À§Çè
  • anesthetic risk
    ¸¶Ãë À§Çèµµ
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇØ ºñÀ²
  • coronary risk factor
    °ü»ó µ¿¸Æ Áúȯ À§Çè ¿äÀÎ
  • explosion risk
    Æø¹ß À§Ç輺
  • operative risk
    ¼ö¼ú À§Çèµµ
  • risk
    À§Çè, À§Çèµµ, À§Ç輺
  • risk factor
    À§Çè ¿äÀÎ, À§Çè ¿ä¼Ò, À§Çè ÀÎÀÚ
    °³ÀÎÀ̳ª ´Üü°¡ ÁúȯÀ̳ª Àå¾Ö¿¡ °É¸®±â ½±°Ô ÇÏ´Â ¿øÀÎÀÌ µÇ´Â ¿ä¼Ò·Î¼­ ¹Î°¨ÇÑ »ç¶÷µé¿¡¼­ ¹ß»ý ºóµµ¿Í Á¤µµ¸¦ Áõ°¡½ÃŲ´Ù.
  • risk management
    ¼úÀÚÀÇ ¾ÈÀü ¼öÄ¢
  • risk principle
    À§Çèµµ ¿ø¸®
  • percutaneous
    °æÇÇÀÇ
    Á¶¿µÁ¦¸¦ ÇǺθ¦ ÅëÇÏ¿© ÁÖ»çÇϵ簡, ħ »ý°ËÀ¸·Î Á¶Á÷À» äÃëÇÏ´Â °Í°ú °°Àº, ÇǺθ¦ ÅëÇÏ¿© ÇàÇÏ´Â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
percutaneous transluminal angioplasty An operation for enlarging a narrowed vascular lumen by inflating and withdrawing through the stenotic region a balloon on the tip of an angiographic catheter; may include positioning of an intravascular stent.
(05 Mar 2000)
percutaneous transluminal coronary angioplasty Percutaneous transluminal angioplasty of coronary artery or arteries.
(05 Mar 2000)
transluminal percutaneous coronary angioplasty <cardiology, procedure> Dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.
(07 Mar 2000)
pregnancy, high-risk Pregnancy in which the mother and/or foetus are at greater than normal risk of morbidity or mortality. Causes include lack of adequate prenatal care, previous obstetrical history, pre-existing maternal disease or pregnancy-induced disease, and multiple gestation, as well as advanced maternal age.
(12 Dec 1998)
angioplasty <cardiology, surgery> The surgical repair of a blood vessel. A balloon angioplasty is a noninvasive procedure where a balloon-tipped catheter is introduced into a diseased blood vessel. As the balloon is inflated, the vessel opens further allowing for improved flow of blood.
(12 Nov 1997)
angioplasty balloon A balloon near the tip of an angiographic catheter, designed to distend narrowed vessels.
See: balloon-tip catheter.
(05 Mar 2000)
balloon angioplasty <cardiology> Use of a balloon catheter for dilatation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of balloon dilatation in coronary arteries, angioplasty, transluminal, percutaneous coronary is available.
Coronary angioplasty is accomplished using a balloon-tipped catheter inserted through an artery in the groin or arm to enlarge a narrowing in a coronary artery. Coronary artery disease occurs when cholesterol plaque builds up (atherosclerosis) in the walls of the arteries to the heart.
Angioplasty is successful in opening coronary arteries in 90% of patients. 40% of patients with successful coronary angioplasty will develop recurrent narrowing at the site of balloon inflation.
(05 Mar 2000)
coronary angioplasty <cardiology, procedure> Percutaneous coronary angioplasty. This procedure involves the introduction of a thin flexible, hollow catheter into a artery in the groin. The catheter is advanced through the blood vessel to the heart. A special balloon tip on the catheter allows the physician to open a diseased (occluded) coronary artery by inflating the balloon and dilating the diseased vessel.
(27 Sep 1997)
laser angioplasty <cardiology, procedure> A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels.
This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an excimer laser which creates microscopically precise cuts without thermal injury.
When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (angioplasty, balloon, laser-assisted).
(05 Mar 2000)
laser-assisted balloon angioplasty <cardiology, procedure> Techniques using laser energy in combination with a balloon catheter to perform angioplasty.
These procedures can take several forms including:
1. Laser fibre delivering the energy while the inflated balloon centres the fibre and occludes the blood flow.
2. Balloon angioplasty immediately following laser angioplasty.
3. Laser energy transmitted through angioplasty balloons that contain an internal fibre.
(05 Mar 2000)
percutaneous <technique> Performed through the skin, as injection of radiopacque material in radiological examination or the removal of tissue for biopsy accomplished by a needle.
Origin: L. Cutis = skin
(18 Nov 1997)
percutaneous absorption The absorption of drugs, allergens, and other substances through unbroken skin.
Synonym: cutaneous absorption.
(05 Mar 2000)
percutaneous cholangiography Radiography of the biliary system after introduction of contrast medium by introducing a needle through the skin inferior to the right costal margin, and inserting it into the substance of the liver or into the gallbladder.
(05 Mar 2000)
percutaneous nephrostomy Drainage of the collecting system through a catheter inserted through the skin of the flank under fluoroscopic control, usually using the Seldinger technique.
(05 Mar 2000)
percutaneous stimulation Electrical stimulation of the peripheral nerves or spinal cord by the application of electrodes to the skin.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 1 ÆäÀÌÁö: 1
  • High Risk Percutaneous Transluminal Angioplasty - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • percutaneous
    ÇǺθ¦ ÅëÇØ¼­ÀÇ;ÇǺΠ°üÅëÀÇ(ÁÖ»çµî)
  • risk
    À§Çè
  • run a risk
    ¸ðÇèÇÏ´Ù
  • calculated risk
    ¿¹ÃøµÇ´Â À§Çè(½ÇÆÐ)
  • catastrophe risk
    ºñ»ó ÀçÇØ À§Çè
  • country risk
    ±¹°¡º° À§Çèµµ(ÇØ¿Ü À¶ÀÚ¸¦ ÇØÁÙ ¶§ÀÇ À¯ÀÚ ´ë»ó±¹ÀÇ ½Å¿ëµµ)
  • risk
    À§Çè(¼º);¸ðÇè;À§Çè(·ü);º¸Çè±Ý(¾×);ÇǺ¸ÇèÀÚ(¹°);À§Å·ӰÔÇÏ´Ù;¸ðÇèÇÏ´Ù;(À§ÇèµîÀ»)°¢¿ÀÇϰí ÀÖ´Ù;°¨ÇàÇÏ´Ù;°¨È÷...ÇÏ´Ù
  • risk capital
    =VENTURE CAPITAL
  • risk manager
    º¸Çè ´ã´ç ÀÓÁ÷¿ø
  • risk-benefit ratio
    À§Ç輺°ú ¼öÀͼº°úÀÇ ºñÀ²
  • risk-money
    ºÎÁ·±Ý º¸»ó ¼ö´ç(ÀºÇà µî¿¡¼­ Ãâ³³°è¿ø¿¡°Ô ÁÖ´Â)
  • security risk
    (Ä¡¾È»óÀÇ)À§Çè Àι°
  • war risk insurance
    ÀüÀï º¸Çè
  • breast-high
    °¡½¿±îÁö ³ôÀÌÀÇ
  • high
    ³ôÀº,°í±ÞÀÇ,³ôÀÌ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á